Search Results 381-390 of 14777 for anti-TNF drugs

  1. New progress in development of gene therapy for arthritis - Mayo Clinic

    Treatment of arthritis is limited by the pharmacokinetics of joints, which impede the sustained, intra-articular delivery of therapeutic agents.

  2. Vitamin B-6 - Mayo Clinic

    Certain autoimmune disorders, some epilepsy medications and alcohol dependence also can lead to vitamin B-6 deficiency. This can cause a condition in which you ...

  3. Oxtriphylline And Guaifenesin (Oral Route) Before Using - Mayo Clinic

    Adalimumab; Adenosine; Amifampridine; Bupropion ... drugs may be the best treatment for you. If both ... medicines. Adinazolam; Alprazolam ...

  4. Assessing the Role of "Statin" Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery - Mayo Clinic

    Use of anti-inflammatory medications listed below within the last 30 days: Leflunomide; Sulfasalazine; Mycophenolate; Cyclosporine; Cyclophosphamide ...

  5. Pegfilgrastim-Bmez (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Pegfilgrastim-bmez injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...

  6. Diclofenac (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  7. Antifungal, Azole (Vaginal Route) Precautions - Mayo Clinic

    Vaginal medicines usually will come out of the vagina during treatment. To keep the medicine from getting on your clothing, wear a minipad or sanitary napkin.

  8. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of WSD0922-FU - Mayo Clinic

    * Any cytotoxic chemotherapy or other anticancer drugs for the treatment ... * Seizures requiring a change in anti-epileptic medications (addition of new ...

  9. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Drugs & Supplements A-Z · Health ... Is naïve to biologic therapy (TNF antagonists or vedolizumab) ... anti-tumor necrosis factors (TNFs) for at least 8 weeks.

  10. Emtricitabine, Rilpivirine, And Tenofovir Alafenamide (Oral Route) Description and Brand Names - Mayo Clinic

    This medicine is usually given to patients who have not received any HIV treatment in the past or to replace their current antiviral medicines provided that ...